Brief: Laurence W. Lytton Reports 9.99% Passive Stake In Evoke Pharma As Of Feb 9, 2024- SEC Filing
13/03/2024 17:38
March 13 (Reuters) -
* LAURENCE W. LYTTON REPORTS 9.99% PASSIVE STAKE IN EVOKE
PHARMA
AS OF FEB 9, 2024- SEC FILING
Source text for Eikon: ID:n0000935836-24-000282
Further company coverage: EVOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary